Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arteris, Inc.AIP · Entity 2399 | Director | December 04, 2024 | December 06, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arteris, Inc.
Report date December 04, 2024 · Filed December 06, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 121,213 |
Reported balance
After 2024-12-04 transaction · row 1
1 source rowRow 1 · 2024-12-04 · Sale · Disposed 15,550 · Balance 121,213 F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 6, 2024. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.10 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 6, 2024.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.10 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2024 Filed Dec 6, 2024 02:10 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 15,550 | $9.03 | $140,455.38 |
DisclosureSEC source: 0001562180-24-008190 · primarydocument.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,213 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 6, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.10 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 21:43 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 19,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004767 · primarydocument.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,763 F1 · shares: Includes 19,287 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 83,863 restricted stock units. The reporting person has elected to defer receipt of 49,026 shares underlying RSUs. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:08 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 29,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004990 · primarydocument.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,476 F1 · shares: Includes 29,027 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:02 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 1,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000306 · primarydocument.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,449 F1 · shares: Fully vested restricted stock. The restricted stock represent retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. The Reporting Person elected to defer receipt of the shares. Read SEC document |
| October 05, 2022 Filed Dec 27, 2022 21:35 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 870 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-008433 · primarydocument.xml · nonDerivative · entry 3 Geday Isabelle F · CIK 0001888675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,994 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. The Reporting Person elected to defer receipt of the shares. F2 · balance_after: Includes 65,194 restricted stock units. The reporting person has elected to defer receipt of 18,544 shares underlying RSUs. Read SEC document |
| July 05, 2022 Filed Dec 27, 2022 21:35 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 757 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-008433 · primarydocument.xml · nonDerivative · entry 2 Geday Isabelle F · CIK 0001888675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,124 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. The Reporting Person elected to defer receipt of the shares. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 22:11 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 16,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-013012 · doc1.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director · VP and GM, IP Employment Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,914 F1 · shares: Represents restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. Read SEC document |
| April 05, 2022 Filed Dec 27, 2022 21:35 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 453 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-008433 · primarydocument.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,367 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. The Reporting Person elected to defer receipt of the shares. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 02:14 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-002403 · doc1.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director · VP and GM, IP Employment Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,450 F1 · shares: Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RUSs will fully (100%) vest upon the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to continued service to the Company through each such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 68,450 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.